Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 851.90
-7.55 (-0.88%)
Aug 22, 2025, 3:29 PM IST
Shilpa Medicare Employees
Shilpa Medicare had 1,007 employees as of March 31, 2024. The number of employees decreased by 172 or -14.59% compared to the previous year.
Employees
1,007
Change (1Y)
-172
Growth (1Y)
-14.59%
Revenue / Employee
13.06M INR
Profits / Employee
1.10M INR
Market Cap
73.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,007 | -172 | -14.59% |
| Mar 31, 2023 | 1,179 | -1,703 | -59.09% |
| Mar 31, 2022 | 2,882 | 388 | 15.56% |
| Mar 31, 2021 | 2,494 | 479 | 23.77% |
| Mar 31, 2020 | 2,015 | 234 | 13.14% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
Shilpa Medicare News
- 10 days ago - Shilpa Medicare Q1 Results: Revenue rises 9.9% to Rs 321 crore, Net profit jumps over 3x YoY - Business Upturn
- 13 days ago - Shilpa Medicare shares jump 3% after CDSCO approval for NorUDCA tablets - Business Upturn
- 15 days ago - Shilpa Medicare gets CDSCO approval for NorUDCA tablets 500 mg, marks first global clearance for NAFLD treatment - Business Upturn
- 5 weeks ago - Shilpa Medicare shares jump nearly 5% after USFDA issues EIR with VAI for Bengaluru unit - Business Upturn
- 7 weeks ago - Shilpa Medicare subsidiary clears GMP inspection from ANVISA with no major observations - Business Upturn
- 3 months ago - Antique cuts target on Shilpa Medicare to Rs 1,090, retains ‘Buy’ on long-term monetization potential - Business Upturn
- 3 months ago - Top stocks to watch today, May 27: Lupin, Aurobindo Pharma, NHPC, KEC International, Shilpa Medicare and more - Business Upturn
- 3 months ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn